Stem cell fusion as an ultimate line of defense against xenobiotics

Medical Hypotheses
Julio Lazaro Padron Velazquez

Abstract

There are several indications that the potential of stem cells to fuse with somatic cells is extremely high and, what's more exciting, in some instances goes as far as reprogramming and/or rescuing altered cells. It remains unclear, however, how frequent this mechanism is and what patho-physiological role it might play in nature. A plausible hypothesis, discussed in this paper, suggests that stem cell niches might provide a safeguard for the intact genome and epigenome. By fusing with somatic de-differentiated cells, stem cells might consent epigenetic reprogramming and/or genetic recovery of genes which otherwise could drive altered cells to malignancy. If the many sophisticated mechanisms of metabolism, cell repair, programmed cell death and tissue regeneration should fail, stem cells might represent a final attempt to recover dedifferentiated cells to avoid inflowing in cancer. In the current reappraisal of the different mechanisms of defense against xenobiotics, even the incidence of cancer itself is considered an evolving mechanism which, through a kind of programmed death of individuals exhibiting defective mutations, favors advancement of the phenotypes which adapt best. Additionally, with regard to the mechanisms of tra...Continue Reading

References

Sep 1, 1992·Cancer Metastasis Reviews·J A Hickman
Jan 29, 1981·Nature·J Cairns
Jul 1, 1994·Medical Hypotheses·M Chigira
Jan 1, 1994·Trends in Biochemical Sciences·S J MartinT G Cotter
Apr 15, 1994·Cancer·J F KerrB V Harmon
Nov 2, 2001·Nature·T ReyaI L Weissman
Nov 16, 2001·Biochemical Society Transactions·M Schuler, D R Green
Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·John Cairns
Dec 20, 2002·Mechanisms of Development·Nelson Fausto, Jean S Campbell
Mar 26, 2003·Seminars in Cancer Biology·Anning Lin, Michael Karin
Apr 1, 2003·Nature·George VassilopoulosDavid W Russell
Sep 25, 2003·Nature Reviews. Molecular Cell Biology·Michael R LieberKlaus Schwarz
Nov 25, 2003·Oncogene·Suzanne CoryJerry M Adams
Jun 15, 2004·Nature Medicine·Holger WillenbringMarkus Grompe
Jun 30, 2004·Trends in Endocrinology and Metabolism : TEM·Anandwardhan A Hardikar
Aug 4, 2004·Genes & Development·Konrad HochedlingerRudolf Jaenisch
Nov 3, 2004·Progress in Neurobiology·Michael J RomankoSteven W Levison
Nov 13, 2004·Stem Cells·Jeong Tae Do, Hans R Schöler
Jan 12, 2005·The Journal of Pathology·Philip J CoatesEric G Wright
Jun 28, 2005·Critical Reviews in Oncology/hematology·Ricky A Sharma, Michael J Browning
Jul 20, 2005·Journal of Clinical Pharmacology·Vera S Donnenberg, Albert D Donnenberg
Sep 29, 2005·Medical Hypotheses·Mesut Tez
Oct 8, 2005·Oncology·Stefanie Schier, Nicholas A Wright
Oct 15, 2005·Current Opinion in Oncology·Freda K Stevenson
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shih-Chieh HungJuri G Gelovani

❮ Previous
Next ❯

Citations

Dec 13, 2007·Rejuvenation Research·Alexandra StolzingSebastian Sethe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Biochemistry. Biokhimii︠a︡
R Holliday
Stem Cell Research & Therapy
María Berdasco, Manel Esteller
Current Pharmaceutical Biotechnology
Rita HumeniukDebabrata Banerjee
© 2021 Meta ULC. All rights reserved